Additionally, studies on cancer cell-CAFs interactions have led to the identification of novel molecular signatures that facilitate immune evasion and tumor progression (40).Overall, these findings underscore the complexity and heterogeneity of CAFs, reinforcing their potential as key regulators of the tumor microenvironment and promising therapeutic targets for improving cancer treatment outcomes (Figure 1). Here, TBX1 is linked to cancer.